Researchers launched a unique collaboration on Wednesday aimed at getting cancer drugs to the market more quickly in which three companies will cooperate with the U.S. government and non-profit groups to test five experimental breast cancer drugs.
The five-year, $26 million study called Investigation of Serial Studies to Predict your Therapeutic Response with Imaging and Molecular Analysis, or I-SPY2, will aim to use DNA to match the best drug to each patient and to more quickly toss out approaches that do not work or are too toxic.
"They'll get the latest and greatest in terms of targeted drugs," Dr. Anna Barker, deputy director of the National Cancer Institute, said in an interview.
"I think it's the future. Government couldn't have done it on their own and these companies couldn't have done it on their own."
Unusually, the companies agreed to share information on using genes to predict how well a patient will respond as part of the Biomarkers Consortium, which includes the U.S. Food and Drug Administration and the National Institutes of Health.
"I-SPY 2 will provide a path to personalized medicine," said Dr. Laura Esserman, a breast cancer surgeon at the University of California San Francisco who will help lead the clinical trials. "We intend that every drug will graduate with a companion marker."
The trial will match patients to one of five experimental drugs:
-- ABT-888 or veliparib, being developed by Abbott Laboratories. The pill is a PARP inhibitor, which blocks a cell repair enzyme used by cancer cells.
-- AMG 655 or conatumumab, a targeted drug being developed by Amgen. It boosts a protein called APO/TRAIL that causes cancer cells to self-destruct.
-- Amgen's AMG 386, an angiogenesis inhibitor that stops tumors from growing blood vessels to nourish themselves.
-- CP-751,871 or figitumumab, being developed by Pfizer Inc to target the insulin growth factor receptor or IGFR.
-- Pfizer's HKI-272 or neratinib, another targeted therapy called a Pan ErbB inhibitor that targets several related receptors used by cancer cells.
The group is negotiating with other companies to add their experimental drugs to the mix.
"It'll speed up the whole process," Barker said.
The drug company lobby group PhRMA estimates it can take as long as 15 years and cost more than $1.3 billion dollars to take a new drug from laboratory to pharmacy.
Patients at 20 cancer centers will be tested right after they get tiny samples of tissue taken in biopsies. Before they ever get surgery, they will be treated with one of the drugs to see if this helps prevent tumor spread.
Up to 12 different cancer drugs will be tested. Unusually, the group has FDA approval to drop and add drugs throughout the course of the trial without having to stop it to write a whole new protocol.
151 people who came into direct contact with the victim were also placed in quarantine.
Viruses that spread through air - such as flu viruses for example - are far more likely to spread swiftly and widely in human populations
TV report that showed workers picking up meat from a factory floor, as well as mixing meat beyond its expiration date with fresh meat
Religious leaders to preach in their churches and mosques for a change of attitude towards the disease
The three people in the latest reported cases had "mild symptoms" and have fully recovered after being treated with antibiotics, the department said, adding that they are no longer contagious.
A state landmark, Mount Rainier last erupted in the 19th century. It is widely expected to erupt again, according to the U.S. National Park Service.
The new vaccine will help save the lives of hundreds of thousands of South Sudanese children.
Food security became a hot topic after record high grain prices in 2008 marked the start of a period of volatility.
An agreement by the court with the advocate general's opinion would have significant repercussions on employers as they could be required to make special adjustments for morbidly obese employees
Steroid-containing inhalers' potential effect on children's growth is a source of worry for parents and doctors
The hole was found near the Bovanentsky gas field, leading to speculation that it could have been caused by an underground explosion.
A team at McGill University developed a pill that cures a form of blindness that usually affects newborns.
Since 2001, new HIV infections have fallen by 38 percent, AIDS-related deaths have fallen by 35 percent since a peak in 2005.
New disclosures about mishaps at U.S. government laboratories handling dangerous pathogens have raised calls for new scrutiny of such research nationwide
Sierra Leone recorded the highest number of deaths, which include confirmed, probable and suspect cases of Ebola, with 52. Liberia reported 13 and Guinea 3
Terrified villagers are shutting off their communities to medical workers, even blocking roads and downing bridges.